Ackermann G - Search Results

1

Mucosal-associated invariant T-Cell (MAIT) activation is altered by chlorpyrifos- and glyphosate-treated commensal gut bacteria.

Mendler A, Geier F, Haange SB, Pierzchalski A, Krause JL, Nijenhuis I, Froment J, Jehmlich N, Berger U, Ackermann G, Rolle-Kampczyk U, von Bergen M, Herberth G. Mendler A, et al. Among authors: ackermann g. J Immunotoxicol. 2020 Dec;17(1):10-20. doi: 10.1080/1547691X.2019.1706672. J Immunotoxicol. 2020. PMID: 31909636

2

The Activation of Mucosal-Associated Invariant T (MAIT) Cells Is Affected by Microbial Diversity and Riboflavin Utilization in vitro.

Krause JL, Schäpe SS, Schattenberg F, Müller S, Ackermann G, Rolle-Kampczyk UE, Jehmlich N, Pierzchalski A, von Bergen M, Herberth G. Krause JL, et al. Among authors: ackermann g. Front Microbiol. 2020 Apr 22;11:755. doi: 10.3389/fmicb.2020.00755. eCollection 2020. Front Microbiol. 2020. PMID: 32390989 Free PMC article.

3

Prevalence and characteristics of bacteria and host factors in an outbreak situation of antibiotic-associated diarrhoea.

Ackermann G, Thomalla S, Ackermann F, Schaumann R, Rodloff AC, Ruf BR. Ackermann G, et al. Among authors: ackermann f. J Med Microbiol. 2005 Feb;54(Pt 2):149-153. doi: 10.1099/jmm.0.45812-0. J Med Microbiol. 2005. PMID: 15673508

4

Antimicrobial phenotypes and molecular basis in clinical strains of Clostridium difficile.

Schmidt C, Löffler B, Ackermann G. Schmidt C, et al. Among authors: ackermann g. Diagn Microbiol Infect Dis. 2007 Sep;59(1):1-5. doi: 10.1016/j.diagmicrobio.2007.03.009. Epub 2007 May 16. Diagn Microbiol Infect Dis. 2007. PMID: 17509804

5

Effect of sub-MIC concentrations of metronidazole, vancomycin, clindamycin and linezolid on toxin gene transcription and production in Clostridium difficile.

Gerber M, Walch C, Löffler B, Tischendorf K, Reischl U, Ackermann G. Gerber M, et al. Among authors: ackermann g. J Med Microbiol. 2008 Jun;57(Pt 6):776-783. doi: 10.1099/jmm.0.47739-0. J Med Microbiol. 2008. PMID: 18480337

6

Comparative activity of moxifloxacin in vitro against obligately anaerobic bacteria.

Ackermann G, Schaumann R, Pless B, Claros MC, Goldstein EJ, Rodloff AC. Ackermann G, et al. Eur J Clin Microbiol Infect Dis. 2000 Mar;19(3):228-32. doi: 10.1007/s100960050465. Eur J Clin Microbiol Infect Dis. 2000. PMID: 10795599

7

Drugs of the 21st century: telithromycin (HMR 3647)--the first ketolide.

Ackermann G, Rodloff AC. Ackermann G, et al. J Antimicrob Chemother. 2003 Mar;51(3):497-511. doi: 10.1093/jac/dkg123. J Antimicrob Chemother. 2003. PMID: 12615850 Review.

8

Prevalence and association of macrolide-lincosamide-streptogramin B (MLS(B)) resistance with resistance to moxifloxacin in Clostridium difficile.

Ackermann G, Degner A, Cohen SH, Silva J Jr, Rodloff AC. Ackermann G, et al. J Antimicrob Chemother. 2003 Mar;51(3):599-603. doi: 10.1093/jac/dkg112. J Antimicrob Chemother. 2003. PMID: 12615860

9

Effect of moxifloxacin versus imipenem/cilastatin treatment on the mortality of mice infected intravenously with different strains of Bacteroides fragilis and Escherichia coli.

Schaumann R, Blatz R, Beer J, Ackermann G, Rodloff AC. Schaumann R, et al. Among authors: ackermann g. J Antimicrob Chemother. 2004 Feb;53(2):318-24. doi: 10.1093/jac/dkh089. Epub 2004 Jan 16. J Antimicrob Chemother. 2004. PMID: 14729746

10

In vitro activity of OPT-80 against Clostridium difficile.

Ackermann G, Löffler B, Adler D, Rodloff AC. Ackermann G, et al. Antimicrob Agents Chemother. 2004 Jun;48(6):2280-2. doi: 10.1128/AAC.48.6.2280-2282.2004. Antimicrob Agents Chemother. 2004. PMID: 15155234 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

162 results

Search Page